For women who do not breastfeed exclusively, the return of menstruation and ovulation is unpredictable; therefore, the choice of contraception and the timing of contraceptive initiation are critical.

Perrigo's HRA Pharma subsidiary has become the first drugmaker in the US to seek approval for an over-the-counter contraceptive pill. The move comes as access to birth control becomes a pivotal ...